These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


836 related items for PubMed ID: 33037056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.
    Simon TG, Roelstraete B, Hartjes K, Shah U, Khalili H, Arnell H, Ludvigsson JF.
    J Hepatol; 2021 Nov; 75(5):1034-1041. PubMed ID: 34224779
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF.
    Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
    Ebrahimi F, Hagström H, Sun J, Bergman D, Shang Y, Yang W, Roelstraete B, Ludvigsson JF.
    J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
    Bengtsson B, Stål P, Wahlin S, Björkström NK, Hagström H.
    Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
    Loomba R, Wong R, Fraysse J, Shreay S, Li S, Harrison S, Gordon SC.
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
    [Abstract] [Full Text] [Related]

  • 14. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K, Nilsson PM, Lindgren S.
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [Abstract] [Full Text] [Related]

  • 15. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.
    VoPham T, Cravero A, Feld LD, Green P, Feng Z, Berry K, Kim NJ, Vutien P, Mendoza JA, Ioannou GN.
    Cancer Epidemiol Biomarkers Prev; 2023 Aug 01; 32(8):1069-1078. PubMed ID: 37255388
    [Abstract] [Full Text] [Related]

  • 16. Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
    Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Seko Y, Takehara T, Itoh Y, Nakajima A, Masaki N, Torimura T, Saibara T, Karino Y, Chayama K, Tokushige K.
    J Gastroenterol Hepatol; 2019 Sep 01; 34(9):1626-1632. PubMed ID: 30668889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
    Simon TG, Henson J, Osganian S, Masia R, Chan AT, Chung RT, Corey KE.
    Clin Gastroenterol Hepatol; 2019 Dec 01; 17(13):2776-2784.e4. PubMed ID: 31077838
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.